CIK 0000818686
- Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 39148213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-09 | Daniell Richard Exec. VP, European Commercial | Grant or award | +55,287 | 79,187 | ||
| 2021-02-09 | Daniell Richard Exec. VP, European Commercial | Sale | −13,135 | $12.72 | $167K | 66,052 |
| 2021-02-09 | Daniell Richard Exec. VP, European Commercial | Sale | −55,287 | $12.72 | $703K | 10,765 |
| 2021-02-09 | Daniell Richard Exec. VP, European Commercial | Option exercise · Restricted Share Units | −13,135 | 13,135 | ||
| 2020-11-03 | Schultz Kare President and CEO | Option exercise | +212,314 | 482,794 | ||
| 2020-11-03 | Schultz Kare President and CEO | Option exercise · Restricted Share Units | −212,314 | 0 | ||
| 2020-11-01 | Schultz Kare President and CEO | Option exercise | +180,000 | 270,480 | ||
| 2020-11-01 | Schultz Kare President and CEO | Option exercise · Restricted Share Units | −180,000 | 296,389 | ||
| 2020-09-09 | Daniell Richard Exec. VP, European Commercial | Option exercise | +698 | 11,098 | ||
| 2020-09-09 | Daniell Richard Exec. VP, European Commercial | Sale | −333 | $8.98 | $3K | 10,765 |
| 2020-09-09 | Daniell Richard Exec. VP, European Commercial | Option exercise · Restricted Share Units | −698 | 0 | ||
| 2020-09-02 | Hussain Abbas Director | Grant or award · Restricted Share Units | +13,050 | 13,050 | ||
| 2020-08-11 | Peres Nechemia Jacob Director | Option exercise | +7,956 | 25,577 | ||
| 2020-08-11 | Peres Nechemia Jacob Director | Option exercise · Restricted Share Units | −7,956 | 0 | ||
| 2020-08-11 | Nisen Perry Director | Option exercise | +7,956 | 25,577 | ||
| 2020-08-11 | Nisen Perry Director | Option exercise · Restricted Share Units | −7,956 | 0 | ||
| 2020-08-11 | MIGNONE ROBERTO Director | Option exercise | +7,956 | 25,577 | ||
| 2020-08-11 | MIGNONE ROBERTO Director | Option exercise · Restricted Share Units | −7,956 | 0 | ||
| 2020-08-11 | LIEBERMAN GERALD M Director | Option exercise | +7,956 | 35,919 | ||
| 2020-08-11 | LIEBERMAN GERALD M Director | Option exercise · Restricted Share Units | −7,956 | 0 |
Page 53 of 76 · 1,517 trades